Dr Pagliaro on the Use of First-Line Avelumab Maintenance Therapy in Urothelial Carcinoma
October 20th 2023Lance C. Pagliaro, MD, discusses the efficacy of first-line avelumab maintenance therapy, as seen in the phase 3 JAVELIN Bladder 100 trial in patients with advanced urothelial carcinoma.
Read More